4570 — Immuno-Biological Laboratories Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Immuno-Biological Laboratories Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1,034	604	508	614	734
Net Total Accounts Receivable
Net Total Receivables	171	199	174	216	190
Total Inventory
Total Other Current Assets
Total Current Assets	1,593	1,125	1,130	1,165	1,262
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	114	127	120	119	136
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,373	1,838	1,705	1,434	1,619
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	398	145	228	252	258
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	425	209	337	356	353
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,948	1,629	1,368	1,079	1,265
Total Liabilities & Shareholders' Equity	2,373	1,838	1,705	1,434	1,619
Total Common Shares Outstanding